Fitting neurological protein aggregation kinetic data via a 2-step, minimal/"Ockham's razor" model: The Finke-Watzky mechanism of nucleation followed by autocatalytic surface growth

Biochemistry

Volumn 47, Issue 8, 2008, Pages 2413-2427

  Morris, Aimee M ^a   Watzky, Murielle A ^a   Agar, Jeffrey N ^b   Finke, Richard G ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b BRANDEIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLOMERATION; MEDICAL PROBLEMS; NEUROLOGY; NUCLEATION; POLYMERIZATION; REACTION KINETICS;

AUTOCATALYTIC SURFACE GROWTH; KINETIC MODELS; NEUROLOGICAL DISORDERS;

PROTEINS;

ANALYTIC METHOD; ARTICLE; CATALYSIS; KINETICS; NEUROLOGIC DISEASE; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS;

ALPHA-SYNUCLEIN; AMYLOID; AMYLOID BETA-PROTEIN; CATALYSIS; CRYSTALLIZATION; DATA INTERPRETATION, STATISTICAL; HUMANS; KINETICS; MODELS, THEORETICAL; NEURODEGENERATIVE DISEASES; PEPTIDES; PRECIPITATION; SURFACE PROPERTIES;

EID: 39749112546     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi701899y     Document Type: Article

References (68)

1. Blennow, K., de Leon, M. J., and Zetterberg, H. (2006) Alzheimer's disease, Lancet 368, 387-403.
2. Dauer, W., and Przedborski, S. (2003) Parkinson's disease: mechanisms and models, Neuron 39, 889-909.
3. Bates, G. P., and Benn, C. (2002) The polyglutamine diseases, in Huntington's Disease (Bates, G. P., Harper, P. S., Jones, L., Eds.) 3rd ed., pp 429-472, Oxford University Press, Oxford.
4. Bieschke, J., Zhang, Q., Powers, E. T., Lerner, R. A., and Kelly, J. W. (2005) Oxidative metabolites accelerate Alzheimer's amyloidogenesis by a two-step mechanism, eliminating the requirement for nucleation, Biochemistry 44, 4977-4983.
5. Vestergaard, M., Kerman, K., Saito, M., Nagatani, N., Takamura, Y., and Tamiya, E. (2005) A rapid label-free electrochemical detection and kinetic study of Alzheimer's amyloid beta aggregation, J. Am. Chem. Soc. 127, 11892-11893.
6. Lu, K., Jacob, J., Thiyagarajan, P., Conticello, V. P., and Lynn, D. G. (2003) Exploiting amyloid fibril lamination for nanotube self-assembly, J. Am. Chem. Soc. 125, 6391-6393.
7. Dong, J., Shokes, J. E., Scott, R. A., and Lynn, D. G. (2006) Modulating amyloid self-assembly and fibril morphology with Zn(II), J. Am. Chem. Soc. 128, 3540-3542.
8. Zirah, S., Kozin, S., Mazur, A. K., Blond, A., Cheminant, M., Ségalas-Milazzo, I., Debey, P., and Rebuffat, S. (2006) Structural changes of region 1-16 of the Alzheimer disease amyloid β peptide upon zinc binding and in vitro aging, J. Biol. Chem. 281, 2151-2161.
9. Fink, A. L. (2006) The aggregation and fibrillation of α-synuclein, Acc. Chem. Res. 39, 628-634.
10. Sode, K., Usuzaka, E., Kobayashi, N., and Ochiai, S. (2005) Engineered α-synuclein prevents wild type and familial Parkin variant fibril formation, Biochem. Biophys. Res. Commun. 335, 432-436.
11. Chen, S., Ferrone, F. A., and Wetzel, R. (2002) Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation, Proc. Natl. Acad. Sci. U.S.A. 99, 11884-11889.
12. Wetzel, R. (2006) Kinetics and thermodynamics of amyloid fibril assembly, Acc. Chem. Res. 39, 671-679.
13. Ban, T., Yamaguchi, K., and Goto, Y. (2006) Direct observation of amyloid fibril growth, propagation, and adaptation, Acc. Chem. Res. 39, 663-670.
14. Dumoulin, M., Kumita, J. R., and Dobson, C. M. (2006) Normal and aberrant biological self-assembly: Insights from studies of human lysozyme and its amyloidogenic variants, Acc. Chem. Res. 39, 603-610.
15. Oosawa, F., Asakura, S., Hotta, K., Imai, N., and Ooi, T. (1959) G-F transformation of actin as a fibrous condensation, J. Polym. Sci. 37, 323-336.
16. Oosawa, F., and Kasai, M. (1962) A theory of linear and helical aggregations of macromolecules, J. Mol. Biol. 4, 10-21.
17. Wegner, A., and Engel, J. (1975) Kinetics of the cooperative association of actin to actin filaments, Biophys. Chem. 3, 215-225.
18. Frieden, C., and Goddette, D. W. (1983) Polymerization of actin and actin-like systems: evaluation of the time course of polymerization in relation to the mechanism, Biochemistry 22, 5836-5843.
19. Eisenberg, H. (1971) Glutamate dehydrogenase: anatomy of a regulatory enzyme, Acc. Chem. Res. 4, 379-385.
20. Thusius, D., Dessen, P., and Jallon, J.-M. (1975) Mechanism of bovine liver glutamate dehydrogenase self-association, J. Mol. Biol. 92, 413-432.
21. Thusius, D. (1975) Mechanism of bovine liver glutamate dehydrogenase self-assembly: II. Simulation of relaxation spectra for an open linear polymerization proceeding via a sequential addition of monomer units, J. Mol. Biol. 94, 367-383.
22. Jullien, M., and Thusius, D. (1976) Mechanism of bovine liver glutamate dehydrogenase self-assembly: III. Characterization of the association- dissociation stoichiometry with quasi-elastic light scattering, J. Mol. Biol. 101, 397-416.
23. Morris, A. M., Watzky, M. A., and Finke, R. G., A critical review of the literature and future directions towards achieving the goal of determining the mechanism of protein aggregation, in progress.
24. Bishop, M. F., and Ferrone, F. A. (1984) Kinetics of nucleation- controlled polymerization, Biophys. J. 46, 631-644.
25. Firestone, M. P., De Levie, R., and Rangarajan, S. K. (1983) On one-dimesional nucleation and growth of "living" polymers I. Homogeneous nucleation, J. Theor. Biol. 104, 535-552.
26. Rangarajan, S. K., and De Levie, R. (1983) On one-dimensional nucleation and growth of "living" polymers II. Growth at constant monomer concentration, J. Theor. Biol. 104, 553-570,
27. Goldstein, R. F., and Stryer, L. (1986) Cooperative polymerization reactions: analytical approximations, numerical examples, and experimental strategy, Biophys. J. 50, 583-599.
28. Ferrone, F. A., Hofrichter, J., Sunshine, H. R., and Eaton, W. A. (1980) Kinetic studies on photolysis-induced gelation of sickle-cell hemoglobin suggest a new mechanism, Biophys. J. 32, 361-377.
29. Ferrone, F. A., Hofrichter, J., and Eaton, W. A. (1985) Kinetics of sickle hemoglobin polymerization II. A double nucleation mechanism, J. Mol. Biol. 183, 611-631.
30. LaMer, V. K., and Dinegar, R. H. (1950) Theory, production and mechanism of formation of monodispersed hydrosols, J. Am. Chem. Soc. 72, 4847-4854.
31. Watzky, M. A., and Finke, R. G. (1997) Transition metal nanocluster formation kinetic and mechanistic studies. A new mechanism when hydrogen is the reductant: slow, continuous nucleation and fast autocatalytic surface growth, J. Am. Chem. Soc. 119, 10382-10400.
32. Besson, C., Finney, E. E., and Finke, R. G. (2005) A mechanism for transition-metal nanoparticle self-assembly, J. Am. Chem. Soc. 127, 8179-8184.
33. Finney, E. E., and Finke, R. G. Solid-state kinetics and the Avrami and subsequent kinetic models revisited: The Finke-Watzky 2-step nucleation and autocatalytic growth mechanism as the Ockham's razor, phenomenological mechanism for 1st-order phase transitions, in preparation.
34. William of Ockham, 1285-1349, as cited in E. A. Moody (1967) The Encyclopedia of Philosophy, Vol. 7, MacMillan, New York.
35. 13C NMR, Protein Sci. 9, 867-877.
36. Roefs, S. P. F. M., and De Kruif, K. G. (1994) A model for the denaturation and aggregation of β-lactoglobulin, Eur. J. Biochem. 226, 883-889.
37. Sun, S. F. (2004) Diffusion, in Physical Chemistry of Macromolecules: Basic Principles and Issues, 2nd ed., pp 223-242, Wiley and Sons, New York.
38. Westermark, P. (2005) Aspects on human amyloid forms and their fibril polypeptides, FEBS 272, 5942-5949.
39. Golde, T. E., Dickson, D., and Hutton, M. (2006) Filling in the gaps in the Aβ cascade hypothesis of Alzheimer's disease, Curr. Alzheimer's Res. 3, 493-504 and references therein.
40. Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., and Glabe, C. G. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis, Science 300, 486-489.
41. Lomakin, A., Teplow, D. B., Kirschner, D. A., and Benedek, G. B. (1997) Kinetic theory of the fibrillogenesis of the amyloid-β protein, Proc. Natl. Acad. Sci. U.S.A. 94, 7942-7947.
42. Schmidt, A. F., and Smirnov, V. V. (2005) Concept of "magic" number clusters as a new approach to the interpretation of unusual kinetics of the Heck reaction with aryl bromides, Top. Catal. 32, 71-75.
43. Finney, E. E., Ott, L. S., Watzky, M. A., and Finke, R. G., Transition-metal nanocluster kinetic and mechanistic studies en route to nanocluster size control: additional studies of nucleation and growth, manuscript in preparation.
44. Uversky, V. N., Li, J., and Fink, A. L. (2001) Evidence for a partially folded intermediate in α-synuclein fibril formation, J. Biol. Chem. 276, 10737-10744.
45. Ferreira, S. T., Vieira, M. N. N., and De Felice, F. G. (2007) Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases, IUBMB Life 59, 332-345.
46. Walsh, D. M., and Selkoe, D. J. (2007) Aβ oligomers - A decade of discovery, J. Neurochem. 101, 1172-1184.
47. Harper, J. D., Wong, S. S., Lieber, C. M., and Lansbury, P. T., Jr. (1999) Assembly of Aβ amyloid protofibrils. An in vitro model for a possible early event in Alzheimer's disease, Biochemistry 38, 8972-8980.
48. Volles, M. J., and Lansbury, P. T., Jr. (2003) Zeroing in on the pathogenic form of α-synuclein and its mechanism of neurotoxicity in Parkinson's disease, Biochemistry 42, 7871-7878.
49. Chromy, B. A., Nowak, R. J., Lambert, M. P., Viola, K. L., Chang, L., Velasco, P. T., Jones, B. W., Fernandez, S. J., Lacor, P. N., Horowitz, P., Finch, C. E., Krafft, G. A., and Klein, W. L. (2003) Self-assembly of Aβ(1- 42) into globular neurotoxins, Biochemistry 42, 12749-12760.
50. Kaylor, J., Bodner, N., Edridge, S., Yamin, G., Hong, D.-P., and Fink, A. L. (2005) Characterization of oligomeric intermediates in α-synuclein fibrillation. FRET studies of Y125W/Y133F/Y136F α-synuclein, J. Mol. Biol. 353, 357-372.
51. Tabner, B. J., El-Agnaf, O. M. A., Turnbull, S., German, M. J., Paleologou, K. E., Hayashi, Y., Cooper, L. J., Fullwood, N. J., and Allsop, D. (2005) Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer's disease and familial British dementia, J. Biol. Chem. 280, 35789-35792.
52. El-Agnaf, O. M. A., Salem, S. A., Paleologou, K. E., Curran, M. D., Gibson, M. J., Court, J. A., Schlossmacher, M. G., and Allsop, D. (2006) Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson's disease, FASEB J. 20, 419-425.
53. Finney, E. E., and Finke, R. G. Transition-metal nanocluster size vs. formation time: a mechanism-based treatment, in preparation.
54. Watzky, M. A., Morris, A. M., and Finke, R. G. Studies in progress.
55. 2: evidence for an autocatalytic reaction pathway with an unusual preference for Sn-Me transfer, J. Am. Chem. Soc., accepted for publication.
56. Eaton, W. A., and Hofrichter, J. (1990) Sickle cell hemoglobin polymerization, in Advance s in Protein Chemistry, Vol. 40, p 159, Academic Press, San Diego.
57. DuBay, K. F., Pawar, A. P., Chiti, F., Zurdo, J., Dobson, C. M., and Venruscolo, M. (2004) Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains, J. Mol. Biol. 341, 1317-1326.
58. (2003) McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed., p 807, McGraw-Hill, New York.
59. Eigen, M. (1996) Prionics or the kinetic basis of prion disease, Biophys. Chem. 63, A1-A18.
60. Prusiner, S. B. (1991) Molecular biology of prion diseases, Science 252, 1515-1522.
61. Cohen, F. E., Pan, K.-M., Huang, Z., Baldwin, M., Fletterick, R. J., and Prusiner, S. B. (1994) Structural clues to prion replication, Science 264, 530-531.
62. Jarrett, J. T., and Lansbury, Jr., P. T. (1993) Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and Scrapie?, Cell 73, 1055-1058.
63. Come, J. H., Fraser, P. E., and Lansbury, P. T., Jr. (1993) A kinetic model for amyloid formation in the prion diseases: importance of seeding, Proc. Natl. Acad. Sci. U.S.A. 90, 5959-5963.
64. Lansbury, P. T. (1994) Mechanism of scrapie replication, Science 265, 1510.
65. Lansbury, P. T., Jr. and Caughey, B. (1995) The chemistry of scrapie infection: implications of the 'ice 9' metaphor, Chem. Biol. 2, 1-5.
66. Caughey, B., Kocisko, D. A., Raymond, G. J., and Lansbury, P. T., Jr. (1995) Aggregates of scrapie-associated prion protein induce the cell-free conversion of protease-sensitive prion protein to the protease-resistant state, Chem. Biol. 2, 807-817.
67. Yamamoto, S., and Gejyo, F. (2005) Historical background and clinical treatment of dialysis-related amyloidosis, Biochim. Biophys. Acta 1753, 4-10.
68. Pepys, M. B., Hawkins, P. N., Booth, D. R., Vigushin, D. M., Tennent, G. A., Soutar, A. K., Totty, N., Nguyen, O., Blake, C. C. F., Terry, C. J., Feest, T. G., Zalin, A. M., and Hsuan, J. J. (1993) Human lysozyme gene mutations cause hereditary systemic amyloidosis, Nature 362, 553-557.